参考文献/References:
[1]NIS Database Documentation.https:www.hcup-us.ahrq.govdb nation nis nisdbdocumentation.jsp.
[2]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2016》概要[J].中国循环杂志,2017,32(6):521-530.
[3]Movahed MR,Ramaraj R,Hashemzadeh M,et al.Nationwide trends in the age adjusted prevalence of non-ST elevation myocardial infarction(NSTEMI)across various races and gender in the USA[J].Acute Card Care,2010,12(2):58-62.
[4]Movahed MR,Ramaraj R,Hashemzadeh M,et al.Rate of acute ST-elevation myocardial infarction in the United States from 1988 to 2004 from the Nationwide Inpatient Sample[J].Am J Cardiol,2009,104(1):5-8.
[5]Towfighi A,Markovic D,Ovbiagele B.National gender-specific trends in myocardial infarction hospitalization rates among patients aged 35 to 64 years[J].Am J Cardiol,2011,108(8):1102-1107.
[6]Ovbiagele B,Markovic D,Fonarow GC.Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction Patients[J].Cardiol Res Pract,2011(2011):145615.
[7]Movahed MR,John J,Hashemzadeh M,et al.Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States(1988-2004)based on race,gender, infarct location and comorbidities[J].Am J Cardiol,2009,104(8):1030-1034.
[8]Agarwal S,Garg A,Parashar A,et al.Outcomes and resource utilization in ST-elevation myocardial infarction in the United States:evidence for socioeconomic disparities[J].J Am Heart Assoc,2014,3(6):e001057.
[9]Patel H,Shivaraju A,Fonarow GC,et al.Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States,1998-2008[J].Am Heart J,2014,168(3):363-373.
[10]Deshmukh A,Kumar G,Pant S,et al.Prevalence of Takotsubo cardiomyopathy in the United States[J].Am Heart J,2012,164(1):66-71.
[11]Brinjikji W,El-Sayed AM,Salka S.In-hospital mortality among patients with takotsubo cardiomyopathy:a study of the National Inpatient Sample 2008 to 2009[J].Am Heart J,2012,164(2):215-221.
[12]Kolte D,Khera S,Aronow WS,et al.Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States:a nationwide population-based study[J].J Am Heart Assoc,2014,3(3):e001056.
[13]Minhas AS,Hughey AB,Kolias TJ.Nationwide Trends in Reported Incidence of Takotsubo Cardiomyopathy from 2006 to 2012[J].Am J Cardiol,2015,116(7):1128-1131.
[14]Afana M,Brinjikji W,Kao D,et al.Characteristics and In-Hospital Outcomes of Peripartum Cardiomyopathy Diagnosed During Delivery in the United States from the Nationwide Inpatient Sample(NIS)Database[J].J Card Fail,2016,22(7):512-519.
[15]Krishnamoorthy P,Garg J,Sharma A,et al.Gender Differences and Predictors of Mortality in Takotsubo Cardiomyopathy: Analysis from the National Inpatient Sample 2009-2010 Database[J].Cardiology,2015,132(2):131-136.
[16]Chen J,Dharmarajan K,Wang Y,et al.National trends in heart failure hospital stay rates,2001 to 2009[J].J Am Coll Cardiol,2013,61(10):1078-1088.
[17]Rodriguez F,Wang Y,Johnson CE,et al.National patterns of heart failure hospitalizations and mortality by sex and age[J].Journal of Cardiac Failure,2013,19(8):542-549.
[18]Ziaeian B,Sharma PP,Yu TC,et al.Factors associated with variations in hospital expenditures for acute heart failure in the United States[J].Am Heart J,2015,169(2):282-289.
[19]Webster G,Zhang J,Rosenthal D.Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations:a retrospective,cross-sectional study[J].BMC CardiovascDisord,2006(6):23.
[20]Sideris C,Alshurafa N,Pourhomayoun M,et al.A data-driven feature extraction framework for predicting the severity of condition of congestive heart failure patients[C].Proceeding of International Conference of the IEEE Engineering in Medicine and Biology Society.IEEE,2015:2534-2537.
[21]Egbe A,Uppu S,Lee S,et al.Temporal Variation of Birth Prevalence of Congenital Heart Disease in the United States[J].Congenital Heart Disease,2015,10(1):43-50.
[22]Opotowsky AR,Siddiqi OK,Webb GD.Trends in hospitalizations for adults with congenital heart disease in the U.S[J].J Am Coll Cardiol,2009,54(5):460-467.
[23]Opotowsky AR,Siddiqi OK,D'Souza B,et al.Maternal cardiovascular events during childbirth among women with congenital heart disease[J].Heart,2012,98(2):145-151.
相似文献/References:
[1]郭俊林,张 立.基质金属蛋白酶-2与冠状动脉粥样硬化性疾病的研究进展[J].医学信息,2018,31(04):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
GUO Jun-lin,ZHANG Li.Progress of the Researchon Matrix Metalloproteinase-2 and Coronary Atherosclerotic Disease[J].Journal of Medical Information,2018,31(07):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
[2]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Journal of Medical Information,2022,35(07):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[3]李 晶,黄 波.抗血小板药物治疗心血管疾病的研究现状[J].医学信息,2022,35(10):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
LI Jing,HUANG Bo.Research Status of Antiplatelet Drugs in the Treatment of Cardiovascular Diseases[J].Journal of Medical Information,2022,35(07):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
[4]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Journal of Medical Information,2022,35(07):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[5]徐炜棉,郭金莲,王燕琴,等.铁代谢及铁蛋白与心血管疾病关系的现状分析[J].医学信息,2018,31(22):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
XU Wei-mian,GUO Jin-lian,WANG Yan-qin,et al.Analysis of the Relationship between Iron Metabolism and Ferritin and Cardiovascular Diseases[J].Journal of Medical Information,2018,31(07):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
[6]刘瑞芳,赵 华,史红娟,等.益生菌与2型糖尿病心血管疾病的研究进展[J].医学信息,2019,32(18):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
LIU Rui-fang,ZHAO Hua,SHI Hong-juan,et al.Advances in Research on Probiotics and Cardiovascular Diseases in Type 2 Diabetes[J].Journal of Medical Information,2019,32(07):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
[7]闫娜娜,李雪萍,李 亚,等.FGF23与心血管疾病的研究进展[J].医学信息,2019,32(19):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
YAN Na-na,LI Xue-ping,LI Ya,et al.Progress in Research on FGF23 and Cardiovascular Diseases[J].Journal of Medical Information,2019,32(07):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
[8]袁国铭,陈新利,袁国娜,等.心脏病健康知识系统构建与应用[J].医学信息,2019,32(22):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
YUAN Guo-ming,CHEN Xin-li,YUAN Guo-na,et al.The Construction and Application of Heart Health Knowledge System[J].Journal of Medical Information,2019,32(07):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
[9]杨 敏,汤云昭,倪长林.2型糖尿病患者心血管疾病的发病机制[J].医学信息,2020,33(06):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
YANG Min,TANG Yun-zhao,NI Chang-lin.The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes[J].Journal of Medical Information,2020,33(07):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
[10]左 楠,刘文辉,李 伟,等.牙周炎与心血管疾病联系机制的研究[J].医学信息,2021,34(10):50.[doi:10.3969/j.issn.1006-1959.2021.10.014]
ZUO Nan,LIU Wen-hui,LI Wei,et al.Study on the Link Mechanism Between Periodontitis and Cardiovascular Disease[J].Journal of Medical Information,2021,34(07):50.[doi:10.3969/j.issn.1006-1959.2021.10.014]